- $1.35bn
- $1.36bn
- $360.53m
- 65
- 33
- 81
- 64
Annual balance sheet for Maxlinear, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 149 | 131 | 206 | 187 | 119 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 67.4 | 120 | 171 | 171 | 85.5 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 362 | 404 | 563 | 488 | 323 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 61.4 | 88.2 | 108 | 97.7 | 77.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,022 | 1,050 | 1,180 | 1,080 | 865 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 234 | 207 | 341 | 222 | 182 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 631 | 561 | 504 | 394 | 348 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 391 | 489 | 676 | 686 | 516 |
| Total Liabilities & Shareholders' Equity | 1,022 | 1,050 | 1,180 | 1,080 | 865 |
| Total Common Shares Outstanding |